US pharma major AbbVie saw its shares drop 4.5% to $218.04 by close of trading on Friday, despite reporting financial results for the third quarter ended September 30, 2025, that beat expectation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback